Cite
HARVARD Citation
Giakoustidis, A. et al. (n.d.). TOPK Inhibitor HI-TOP-32 administration in DEN-induced hepatocarcinogenesis in C57BL/6 mice results in tumour regression. HPB. pp. e155-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Giakoustidis, A. et al. (n.d.). TOPK Inhibitor HI-TOP-32 administration in DEN-induced hepatocarcinogenesis in C57BL/6 mice results in tumour regression. HPB. pp. e155-. [Online].